* Privia Health Group Inc PRVA.OQ PRVA.O is expected
to show a
rise in quarterly revenue when it reports results on May 4.
* The Arlington Virginia-based company is expected to
report a
16.2% increase in revenue to $652.97 million from $561.9 million
a year ago, according to the mean estimate from 11 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Privia Health Group
Inc
is for earnings of 2 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 18 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.9%
in the last three months.
* Wall Street's median 12-month price target for Privia
Health
Group Inc is $39.5, above its last closing price of $27.98.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.03 -0.03 0.14 Beat 606.5
Sep. 30 2022 0.00 0.00 0.01 Beat 109.2
Jun. 30 2022 -0.02 -0.03 0.14 Beat 636.2
Mar. 31 2022 -0.05 -0.04 -0.16 Missed -340.4
Dec. -0.18 -0.13 -0.11 Beat 17.7
31 2021
Sep. 30 2021 -0.09 -0.11 -0.09 Beat 16.9
Jun. 30 2021 -1.76 -1.69 -1.68 Beat 0.6
Mar. 31 2021 0.04 0.04 0.06 Beat 36.9
This summary was machine generated May 2 at 18:38 GMT. All
figures in US dollars unless otherwise stated